Advocacy
Accomplishments
Report 2020
fightcancer.org
fightcancer.org
Dear Friends,
It can’t be overstated: 2020 was an exceptional year. Like so many other aspects of our lives, the fight against cancer was transformed in ways nearly unimaginable prior to the COVID-19 pandemic. The onset of enormous public health and financial crises meant we had to rethink and adjust how we influenced and advanced public policies to benefit the more than 16.9 million Americans with a history of cancer and the millions who were newly diagnosed during this time. Without hesitation, volunteers and staff rose to meet the moment.
As the nation’s leading cancer advocacy organization, the American Cancer Society Cancer Action NetworkSM (ACS CAN) has an unwavering commitment to safeguarding and bettering the health of all cancer patients, survivors and their loved ones – many of whom faced heightened risk due to the pandemic. ACS CAN staff and volunteers successfully pivoted our advocacy agenda to an almost entirely virtual format, finding ways to continue to connect with elected officials at all levels of government and urging them to enact policies to mitigate the significant effects of the pandemic by increasing access to quality, affordable health care. Cancer didn’t stop, so neither did we. Together, we demanded that cancer remain a national priority by elevating the voices of cancer patients and survivors in every state, Washington, D.C., Puerto Rico and Guam.
Perhaps what I am most proud of this year are the many execution strategies to further our health equity goals. Increased attention to widespread, systemic racial injustice in our country – compounded by the disparate impact of the pandemic on communities of color – has demanded renewed urgency in our efforts to address disparities in cancer care and health outcomes. Through our public policy agenda, ACS CAN remains steadfastly committed to partnering with lawmakers, civic leaders and organizations to ensure everyone has a fair and just opportunity to prevent, find, treat and survive cancer.
We could not have maintained our important progress forward without the critical support of our generous donors, our passionate volunteers and the many individuals and organizations that stood by us in this work and helped us overcome every barrier placed in our way. We are incredibly thankful for these partnerships.
I am immensely honored to lead an organization that has driven meaningful change and impact in a year of remarkable challenges and look forward to continuing our ever-important mission of relentlessly pursuing a world without cancer.
Lisa A. Lacasse, MBA
President, ACS CAN
Dear Friends,
It can’t be overstated: 2020 was an exceptional year. Like so many other aspects of our lives, the fight against cancer was transformed in ways nearly unimaginable prior to the COVID-19 pandemic. The onset of enormous public health and financial crises meant we had to rethink and adjust how we influenced and advanced public policies to benefit the more than 16.9 million Americans with a history of cancer and the millions who were newly diagnosed during this time. Without hesitation, volunteers and staff rose to meet the moment.
As the nation’s leading cancer advocacy organization, the American Cancer Society Cancer Action NetworkSM (ACS CAN) has an unwavering commitment to safeguarding and bettering the health of all cancer patients, survivors and their loved ones – many of whom faced heightened risk due to the pandemic. ACS CAN staff and volunteers successfully pivoted our advocacy agenda to an almost entirely virtual format, finding ways to continue to connect with elected officials at all levels of government and urging them to enact policies to mitigate the significant effects of the pandemic by increasing access to quality, affordable health care. Cancer didn’t stop, so neither did we. Together, we demanded that cancer remain a national priority by elevating the voices of cancer patients and survivors in every state, Washington, D.C., Puerto Rico and Guam.
Perhaps what I am most proud of this year are the many execution strategies to further our health equity goals. Increased attention to widespread, systemic racial injustice in our country – compounded by the disparate impact of the pandemic on communities of color – has demanded renewed urgency in our efforts to address disparities in cancer care and health outcomes. Through our public policy agenda, ACS CAN remains steadfastly committed to partnering with lawmakers, civic leaders and organizations to ensure everyone has a fair and just opportunity to prevent, find, treat and survive cancer.
We could not have maintained our important progress forward without the critical support of our generous donors, our passionate volunteers and the many individuals and organizations that stood by us in this work and helped us overcome every barrier placed in our way. We are incredibly thankful for these partnerships.
I am immensely honored to lead an organization that has driven meaningful change and impact in a year of remarkable challenges and look forward to continuing our ever-important mission of relentlessly pursuing a world without cancer.
Lisa A. Lacasse, MBA
President, ACS CAN
Table of contents
WHO We Are
and How we Deliver Impact
Cancer Votes
Public Health Crises in 2020
Cancer Didn’t Stop and Neither did we
Accelerating
Cures
Prevention
and Early Detection
Access to Care
Looking Forward
2020 impact
at-a-glance
special thanks
Table of contents
WHO We Are
and How we Deliver Impact
Cancer Votes
Public
Health Crises
in 2020
Cancer Didn’t Stop and Neither did we
Accelerating
Cures
Prevention
and Early
Detection
Access
to Care
Looking
Forward
2020 impact
at-a-glance
special
thanks
ACS CAN is strictly nonpartisan and does not endorse, oppose or contribute to candidates or political parties.
The only side ACS CAN takes is the side of cancer patients and survivors.
As the American Cancer Society’s nonprofit, nonpartisan advocacy affiliate, ACS CAN staff work closely with American Cancer Society experts to identify and develop evidence-based public policies that promote access to prevention and early detection, treatment and follow-up care.
The American Cancer Society Cancer Action Network (ACS CAN) is making cancer a top priority for public and elected officials, as well as candidates at the federal, state and local levels, by empowering advocates across the country to make their voices heard.
ACS CAN is strictly nonpartisan and does not endorse, oppose or contribute to candidates or political parties.
As the American Cancer Society’s nonprofit, nonpartisan advocacy affiliate, ACS CAN staff work closely with American Cancer Society experts to identify and develop evidence-based public policies that promote access to prevention and early detection, treatment and follow-up care.
The American Cancer Society Cancer Action Network (ACS CAN) is making cancer a top priority for public and elected officials, as well as candidates at the federal, state and local levels, by empowering advocates across the country to make their voices heard.
The only side ACS CAN takes is the side of cancer patients and survivors.
Volunteers: The Heart of ACS CAN
We engage hundreds of thousands of remarkable individuals in every congressional district across the country – cancer patients and survivors, caregivers and family members, health care providers and researchers – who share their time and skills to advance our mission to eliminate cancer as a major health problem.
Volunteers: The Heart of ACS CAN
We engage hundreds of thousands of remarkable individuals in every congressional district across the country – cancer patients and survivors, caregivers and family members, health care providers and researchers – who share their time and skills to advance our mission to eliminate cancer as a major health problem.
Expert Guidance
We leverage the expertise and insight of our Board of Directors, comprised of physicians, researchers, public health professionals, volunteers and civic leaders.
Bringing Leaders
Together in the
Fight Against Cancer
We convene researchers, medical providers, patient advocates, and public officials to foster discussion and examine public policies that are critical in the fight against cancer.
Judicial Advocacy Initiative
We work with attorneys who donate time and expertise to help advance our mission by representing ACS CAN in influential court cases, regulatory proceedings, and legislative drafting to further mission goals. Learn more about our Judicial Advocacy Initiative at fightcancer.org.
Expert Guidance
We leverage the expertise and insight of our Board of Directors, comprised of physicians, researchers, public health professionals, volunteers and civic leaders.
Bringing Leaders Together in the
Fight Against Cancer
We convene researchers, medical providers, patient advocates, and public officials to foster discussion and examine public policies that are critical in the fight against cancer.
Judicial Advocacy Initiative
We work with attorneys who donate time and expertise to help advance our mission by representing ACS CAN in influential court cases, regulatory proceedings, and legislative drafting to further mission goals. Learn more about our Judicial Advocacy Initiative at fightcancer.org.
Coalitions and Partnerships
We lead and partner with a wide range of organizations to advance our mission priorities and improve our reach among diverse communities across America.
Dr. Kimberly Jeffries Leonard, member of the ACS CAN Board of Directors and president of The Links, Incorporated, appears during the 2020 Lights of Hope Across America live event. The Links, Inc. and ACS CAN partner to address cancer disparities and drive health equity.
1 of 3
2 of 3
3 of 3
1 of 9
2 of 9
3 of 9
4 of 9
5 of 9
6 of 9
7 of 9
8 of 9
9 of 9
2020 also saw instances of racial injustice, including the murders of Ahmaud Arbery, George Floyd and Breonna Taylor, among others, which heightened awareness of systemic racism in America.
These events brought new urgency to ACS CAN’s longstanding commitment to health equity in every aspect of our work and the need to mobilize in a new way to address emerging challenges brought about by the pandemic.
ACS CAN contributes to and advances the American Cancer Society’s commitment to being an anti-racist organization by actively pursuing public policies at all levels of government that seek to improve health outcomes for ALL individuals.
The COVID-19 pandemic has upended daily life and posed unique health care challenges for cancer patients and survivors.
Evidence continues to mount that the pandemic has had outsized effects on communities of color.
2020 also saw instances of racial injustice, including the murders of Ahmaud Arbery, George Floyd and Breonna Taylor, among others, which heightened awareness of systemic racism in America.
These events brought new urgency to
ACS CAN’s longstanding commitment to health equity in every aspect of our work and the need to mobilize in a new way to address emerging challenges brought about by the pandemic.
ACS CAN contributes to and advances the American Cancer Society’s commitment to being an anti-racist organization by actively pursuing public policies at all levels of government that seek to improve health outcomes for all individuals.
The COVID-19 pandemic has upended daily life and posed unique health
care challenges for cancer patients
and survivors.
Evidence continues to mount that the pandemic has had outsized effects on communities of color.
Survivor Views
ACS CAN’s Survivor Views initiative established a cohort of more than 3,000 cancer survivors to participate in regular surveys and share their experiences related to our priority policy issues. We fielded multiple surveys throughout the year to capture snapshots of the patient experience throughout the pandemic, including the number of patients experiencing delays in care and the financial stress and worry caused by the pandemic. The real-time findings from those impacted by cancer have been widely cited by policymakers and media nationwide.
Understanding Access to Care During the COVID-19 Pandemic September 2020 Survey Infographic
COVID-19 Pandemic Ongoing Impact on
Cancer Patients and Survivors
Click infographic thumbnails below for full survey details at fightcancer.org:
Survivor Views
ACS CAN’s Survivor Views initiative established a cohort of more than 3,000 cancer survivors to participate in regular surveys and share their experiences related to our priority policy issues. We fielded multiple surveys throughout the year to capture snapshots of the patient experience throughout the pandemic, including the number of patients experiencing delays in care and the financial stress and worry caused by the pandemic. The real-time findings from those impacted by cancer have been widely cited by policymakers and media nationwide.
Understanding Access to Care During the COVID-19 Pandemic September 2020 Survey Infographic
COVID-19 Pandemic Ongoing Impact on
Cancer Patients and Survivors
Click infographic thumbnails below
for full survey details at fightcancer.org:
The Medicaid Covers US project hosted a virtual event with Jamila Michener, PhD, Associate Professor at Cornell University and Co-Director of the Cornell Center for Health Equity, about the role of Medicaid in addressing health and racial disparities that have been exacerbated by the COVID-19 pandemic. The webinar also premiered a short film about COVID-19 in the Black Belt of Alabama.
Medicaid Covers US is being funded by general funds from ACS CAN, as well as funds from the American Cancer Society (ACS). ACS is providing support for the public education components of the campaign, which is made possible through a grant from the Robert Wood Johnson Foundation.
Medicaid and COVID-19 Through the Health Equity Lens
Watch: Medicaid Covers US COVID Update
The Medicaid Covers US project hosted a virtual event with Jamila Michener, PhD, Associate Professor at Cornell University and Co-Director of the Cornell Center for Health Equity, about the role of Medicaid in addressing health and racial disparities that have been exacerbated by the COVID-19 pandemic. The webinar also premiered a short film about COVID-19 in the Black Belt of Alabama.
Medicaid Covers US is being funded by general funds from ACS CAN, as well as funds from the American Cancer Society (ACS). ACS is providing support for the public education components of the campaign, which is made possible through a grant from the Robert Wood Johnson Foundation.
Medicaid and COVID-19
Through the Health Equity Lens
Watch: Medicaid Covers US COVID Update
As the pandemic took hold, ACS CAN quickly positioned ourselves to make sure important policy issues that impact cancer patients were included in the public conversation around addressing the current public health and economic crises. Leading a coalition of more than 50 groups, we successfully worked to ensure that congressional relief packages included critical provisions such as funding to restart cancer research and clinical trials, increased funding for state Medicaid programs, expanded access to no-cost COVID-19 testing and 90-day prescription refills, and expanded telehealth provisions that provide patients greater access to in-home care and supportive services.
Pandemic Relief
The pandemic has also affected nonprofit revenue, forcing many organizations including ACS and ACS CAN to face significant financial challenges. As part of a strong coalition, ACS CAN helped to elevate the importance of relief for the nonprofit sector to elected officials. Both the March 2020 CARES Act and December year-end COVID-19 relief package included charitable sector priorities like the Employee Retention Tax Credit (ERTC) and a universal deduction for charitable donations of up to $600 for a couple and $300 for an individual to incentivize additional giving to nonprofits who have faced dwindling support amid surging demand. In addition, ACS CAN actively worked to pass the Protecting Nonprofits from Catastrophic Cash Flow Strain Act of 2020, which was signed into law in August 2020. This new law helps to improve emergency unemployment relief for nonprofits like the American Cancer Society. ACS CAN will continue to advocate for policy provisions, particularly for large nonprofits, that will allow additional funding to support mission execution.
Click thumbnail to open a PDF detailing
ACS CAN’s COVID-19 Advocacy Impact
During the Congressional Black Caucus Foundation’s virtual Annual Legislative Conference, U.S. Rep. Colin Allred and leaders from the professional sports community hosted a conversation featuring stories from cancer survivors and discussed how COVID-19 exacerbated health disparities.
Collaborations to Address Health Disparities
ACS CAN collaborated with members of the Congressional Tri-Caucuses throughout the year to bring together members of Congress, researchers and nonprofit and community leaders to discuss health disparities and drive action toward policy solutions. ACS CAN sponsored virtual events for the Congressional Black Caucus Foundation’s Annual Legislative Conference that examined racial disparities in cancer screenings during the pandemic and how to reengage the Black community in cancer screening, as well as how racial disparities impact cancer survival. We also sponsored the Congressional Hispanic Caucus Institute’s Health Summit, during which ACS CAN President Lisa Lacasse delivered remarks in a discussion on social determinants of health in Latino children, youth and families.
Lisa also partnered with Lori Pierce, MD, president of the American Society of Clinical Oncology, to co-author an editorial piece in Urban One’s Engaging Black America publication about the critical need to address racial disparities in cancer by improving access to high-quality care. We were also proud to join the We Must Count coalition, a group of health equity and civil rights stakeholders fighting for accurate COVID-19 data collection by race, ethnicity, gender, socioeconomic status and other demographic information in an effort to urge policymakers to ensure accurate, timely public health data collection.
Addressing Systemic Racism as a Public Health Concern
ACS CAN supported multiple state-level initiatives to address systemic racism in public health. In one such initiative, Minnesota passed a resolution declaring racism a public health crisis and outlining steps to dismantle it.
Collaborations to
Address Health Disparities
ACS CAN collaborated with members of the Congressional Tri-Caucuses throughout the year to bring together members of Congress, researchers and nonprofit and community leaders to discuss health disparities and drive action toward policy solutions. ACS CAN sponsored virtual events for the Congressional Black Caucus Foundation’s Annual Legislative Conference that examined racial disparities in cancer screenings during the pandemic and how to reengage the Black community in cancer screening, as well as how racial disparities impact cancer survival. We also sponsored the Congressional Hispanic Caucus Institute’s Health Summit, during which ACS CAN President Lisa Lacasse delivered remarks in a discussion on social determinants of health in Latino children, youth and families.
Lisa also partnered with Lori Pierce, MD, president of the American Society of Clinical Oncology, to co-author an editorial piece in Urban One’s Engaging Black America publication about the critical need to address racial disparities in cancer by improving access to high-quality care. We were also proud to join the We Must Count coalition, a group of health equity and civil rights stakeholders fighting for accurate COVID-19 data collection by race, ethnicity, gender, socioeconomic status and other demographic information in an effort to urge policymakers to ensure accurate, timely public health data collection.
Addressing Systemic Racism
as a Public Health Concern
ACS CAN supported multiple state-level initiatives to address systemic racism in public health. In one such initiative, Minnesota passed a resolution declaring racism a public health crisis and outlining steps to dismantle it.
No matter the challenges we face, ACS CAN finds a way to advance our mission.
This year, we greatly expanded our digital advocacy activities so we could continue to raise the voices of cancer patients and survivors while safeguarding the health of our volunteers.
ACS CAN prides itself on bringing together advocates, policymakers, regulators, researchers and health care professionals with a shared goal of improving public health.
The pandemic has raised new challenges for how we advocate, how we celebrate and how we raise awareness.
No matter the challenges we face,
ACS CAN finds a way to advance our mission.
This year, we greatly expanded our digital advocacy activities so we could continue to raise the voices of cancer patients and survivors while safeguarding the health of our volunteers.
ACS CAN prides itself on bringing together advocates, policymakers, regulators, researchers and health care professionals with a shared goal of improving public health.
The pandemic has raised new challenges for how we advocate, how we celebrate and how we raise awareness.
Lights of Hope Across America
This year, ACS CAN took Lights of Hope to communities nationwide with the debut of Lights of Hope Across America. Volunteers helped transition the event, which previously existed exclusively in Washington, D.C., into a nationwide effort, bringing hope home with 52,000 tributes of hope and celebration for cancer survivors and those they have lost in hundreds of cities across all 50 states.
The event represented a 30% increase in volunteer fundraising over last year, a huge accomplishment in such a challenging financial climate. Our volunteers met this challenge with fierce passion and determination, raising more funds than in any previous year to celebrate 10 years of Lights of Hope in 2020.
Video highlights: Lights of Hope Across America
Lights of Hope Across America
This year, ACS CAN took Lights of Hope to communities nationwide with the debut of Lights of Hope Across America. Volunteers helped transition the event, which previously existed exclusively in Washington, D.C., into a nationwide effort, bringing hope home with 52,000 tributes of hope and celebration for cancer survivors and those they have lost in hundreds of cities across all 50 states.
The event represented a 30% increase in volunteer fundraising over last year, a huge accomplishment in such a challenging financial climate. Our volunteers met this challenge with fierce passion and determination, raising more funds than in any previous year to celebrate 10 years of Lights of Hope in 2020.
Video highlights: Lights of Hope Across America
Leadership Summit & Lobby Day
ACS CAN’s 14th annual Leadership Summit & Lobby Day (LS&LD) brought nearly 700 participants from all 50 states, Puerto Rico and the District of Columbia together virtually to meet with more than 450 congressional offices, including 141 member-level meetings and 201 senior-level meetings. They focused their tremendous efforts on advocating for health equity in cancer research, cures and prevention. In addition to funding for the National Institutes of Health (NIH) and the National Cancer Institute (NCI), volunteers advocated for Centers for Disease Control and Prevention (CDC) cancer screening programs that serve low-income, underserved communities and asked for support for the Henrietta Lacks Enhancing Cancer Research Act to reduce barriers to clinical trials enrollment and increase participation from traditionally underrepresented patients. Participants were well-prepared to successfully navigate the new virtual format right from their homes after attending a series of pre-event trainings in the four weeks leading up to LS&LD.
Leadership Summit & Lobby Day
ACS CAN’s 14th annual Leadership Summit & Lobby Day (LS&LD) brought nearly 700 participants from all 50 states, Puerto Rico and the District of Columbia together virtually to meet with more than 450 congressional offices, including 141 member-level meetings and 201 senior-level meetings. They focused their tremendous efforts on advocating for health equity in cancer research, cures and prevention. In addition to funding for the National Institutes of Health (NIH) and the National Cancer Institute (NCI), volunteers advocated for Centers for Disease Control and Prevention (CDC) cancer screening programs that serve low-income, underserved communities and asked for support for the Henrietta Lacks Enhancing Cancer Research Act to reduce barriers to clinical trials enrollment and increase participation from traditionally underrepresented patients. Participants were well-prepared to successfully navigate the new virtual format right from their homes after attending a series of pre-event trainings in the four weeks leading up to LS&LD.
1 of 4
2 of 4
3 of 4
4 of 4
As founder and a leading member of One Voice Against Cancer (OVAC), ACS CAN together with a coalition of more than 50 cancer organizations hosted two lobby days this year advocating for greater federal investments in cancer research. Approximately 55 volunteers from nearly 20 states participated in more than 80 virtual meetings with members of Congress and their staff to advocate for increased funding for NIH, NCI and CDC cancer programs. Additionally, OVAC volunteers advocated for emergency funding for the NIH to restart research and clinical trials impacted by COVID-19.
While many of our state Cancer Action Day events were held in person prior to the COVID-19 pandemic, ACS CAN was able to pivot to online engagement in many states to ensure our volunteers’ voices were heard throughout the year. More than 100 Ohio volunteers participated in a successful Virtual Cancer Action Day in May, joining by videoconference to urge their state lawmakers to support tobacco prevention funding and protect youth from the dangers of indoor tanning. They closed the day with a “Power Hour” to connect with any remaining elected officials who had not been contacted earlier in the day. Pennsylvania volunteers spent their Cancer Week of Action urging their state lawmakers to preserve funding in its annual budget for tobacco cessation and prevention programs by sending 150 emails, posting more than 60 tweets and making nearly 400 phone calls.
The 2020 National Forum on the Future of Health Care featured noted speakers including Scott Gottlieb, former Commissioner of the Food and Drug Administration, and examined new cancer therapies and policy interventions to overcome barriers that keep patients from accessing them.
Below: Gary Reedy, CEO of the American Cancer Society and ACS CAN, spoke during the forum about ACS CAN’s commitment to protecting and expanding patient access to the newest cancer therapies.
ACS CAN hosted 57 virtual state policy forums covering topics ranging from improving access to innovative cancer therapies to addressing health disparities among Native American populations. These events drew prominent speakers including NCI Director Norman Sharpless, MD, and elected officials including Sens. Sheldon Whitehouse (D-RI) and Jack Reed (D-RI) to the table to discuss important issues with our volunteers.
Section 1 of 4
Section 2 of 4
Section 3 of 4
Section 4 of 4
One Voice Against Cancer Lobby Day
As founder and a leading member of One Voice Against Cancer (OVAC), ACS CAN together with a coalition of more than 50 cancer organizations hosted two lobby days this year advocating for greater federal investments in cancer research. Approximately 55 volunteers from nearly 20 states participated in more than 80 virtual meetings with members of Congress and their staff to advocate for increased funding for NIH, NCI and CDC cancer programs. Additionally, OVAC volunteers advocated for emergency funding for the NIH to restart research and clinical trials impacted by COVID-19.
State Cancer Action Day virtual events
While many of our state Cancer Action Day events were held in person prior to the COVID-19 pandemic, ACS CAN was able to pivot to online engagement in many states to ensure our volunteers’ voices were heard throughout the year. More than 100 Ohio volunteers participated in a successful Virtual Cancer Action Day in May, joining by videoconference to urge their state lawmakers to support tobacco prevention funding and protect youth from the dangers of indoor tanning. They closed the day with a “Power Hour” to connect with any remaining elected officials who had not been contacted earlier in the day. Pennsylvania volunteers spent their Cancer Week of Action urging their state lawmakers to preserve funding in its annual budget for tobacco cessation and prevention programs by sending 150 emails, posting more than 60 tweets and making nearly 400 phone calls.
2020 National Forum
on the Future of Health Care
The 2020 National Forum on the Future of Health Care featured noted speakers including Scott Gottlieb, former Commissioner of the Food and Drug Administration, and examined new cancer therapies and policy interventions to overcome barriers that keep patients from accessing them.
Below: Gary Reedy, CEO of the American Cancer Society and ACS CAN, spoke during the forum about ACS CAN’s commitment to protecting and expanding patient access to the newest cancer therapies.
57 virtual state policy forums
ACS CAN hosted 57 virtual state policy forums covering topics ranging from improving access to innovative cancer therapies to addressing health disparities among Native American populations. These events drew prominent speakers including NCI Director Norman Sharpless, MD, and elected officials including Sens. Sheldon Whitehouse (D-RI) and Jack Reed (D-RI) to the table to discuss important issues with our volunteers.
Federal Funding for Cancer Research and Prevention
ACS CAN advocated throughout the year for sustained investment in cancer priorities across key federal agencies, a significant accomplishment in a tough budget environment. A year-end budget deal included:
Federal Funding for Cancer Research and Prevention
ACS CAN advocated throughout the year for sustained investment in cancer priorities across key federal agencies,
a significant accomplishment in a tough budget environment. A year-end budget deal included:
ACS CAN authored and advocated for the Henrietta Lacks Enhancing Cancer Research Act, which successfully passed Congress in December 2020 and was signed into law in early January 2021. Clinical trials are critical to advancing cures for cancer, yet one in five trials fails due to lack of participation. Meanwhile, communities of color and other medically underserved groups have higher cancer rates and are under-represented in clinical trials. This bipartisan legislation will help ensure that progress towards cures continues and people have more equitable access to cutting-edge treatment opportunities. The legislation was a core piece of ACS CAN’s ongoing work to achieve health equity.
Participation in clinical trials advances our search for cures and gives patients access to cutting-edge therapies, but Medicaid recipients can face barriers to enrollment if their routine care costs are not covered during their participation. In 2020, ACS CAN successfully advocated for legislation federally as well as in Colorado, Illinois and Minnesota to ensure routine care costs for Medicaid recipients enrolled in clinical trials are covered. The end-of-year spending bill in Congress included a provision to require that routine care costs are covered for Medicaid recipients in all states across the country. These wins also advance health equity by encouraging diverse participation in clinical trials.
1 of 2
2 of 2
The Henrietta Lacks Enhancing Cancer Research Act is named for a Black woman who died from cervical cancer and whose cells were taken without her knowledge during her treatment. The legislation aims to increase access and remove barriers to participation in federally sponsored cancer clinical trials among communities that are traditionally underrepresented. Photo Credit: The Lacks Family
The Henrietta Lacks Enhancing Cancer Research Act is named for a Black woman who died from cervical cancer and whose cells were taken without her knowledge during her treatment. The legislation aims to increase access and remove barriers to participation in federally sponsored cancer clinical trials among communities that are traditionally underrepresented. Photo Credit: The Lacks Family
Addressing Barriers to
Cancer Clinical Trials
ACS CAN authored and advocated for the Henrietta Lacks Enhancing Cancer Research Act, which successfully passed Congress in December 2020 and was signed into law in early January 2021. Clinical trials are critical to advancing cures for cancer, yet one in five trials fails due to lack of participation. Meanwhile, communities of color and other medically underserved groups have higher cancer rates and are under-represented in clinical trials. This bipartisan legislation will help ensure that progress towards cures continues and people have more equitable access to cutting-edge treatment opportunities. The legislation was a core piece of ACS CAN’s ongoing work to achieve health equity.
Improving Medicaid Coverage
for Clinical Trials Participation
Participation in clinical trials advances our search for cures and gives patients access to cutting-edge therapies, but Medicaid recipients can face barriers to enrollment if their routine care costs are not covered during their participation. In 2020, ACS CAN successfully advocated for legislation federally as well as in Colorado, Illinois and Minnesota to ensure routine care costs for Medicaid recipients enrolled in clinical trials are covered. The end-of-year spending bill in Congress included a provision to require that routine care costs are covered for Medicaid recipients in all states across the country. These wins also advance health equity by encouraging diverse participation in clinical trials.
Section 1 of 2
Section 2 of 2
Improving Access to Biomarker Testing
ACS CAN produced a new report, Improving Access to Biomarker Testing, which highlights advances in precision medicine to treat cancer through the use of biomarker testing. In addition to explaining how biomarker testing works, this report includes recommendations on how to ensure patients can access therapeutics with the highest likelihood of success for their unique cancer.
Click thumbnail for the detailed report,
Improving Access to Biomarker Testing at fightcancer.org.
Improving Access to
Biomarker Testing
ACS CAN produced a new report, Improving Access to Biomarker Testing, which highlights advances in precision medicine to treat cancer through the use of biomarker testing. In addition to explaining how biomarker testing works, this report includes recommendations on how to ensure patients can access therapeutics with the highest likelihood of success for their unique cancer.
Click thumbnail for the detailed report,
Improving Access to Biomarker Testing at fightcancer.org.
A key piece of ACS CAN’s work to prevent cancer is reducing the toll of tobacco use, which represents the nation’s number one cause of preventable death, a public health burden that is perpetuated by the industry’s deceptive practices.
ACS CAN works at every level of government to support public policies that are proven to help equitably prevent and detect cancer and prevent people and youth from starting to
use tobacco.
More than half of all cancer deaths can be prevented by fully leveraging the knowledge, tools and medical breakthroughs we have today.
Providing everyone with the opportunity to have a healthy lifestyle and access to cancer screenings – like mammograms and colonoscopies – could save thousands of lives every year, and eliminate the inequities that exist in the prevention and early detection of cancer.
A key piece of ACS CAN’s work to prevent cancer is reducing the toll of tobacco use, which represents the nation’s number one cause of preventable death, a public health burden that is perpetuated by the industry’s deceptive practices.
ACS CAN works at every level of government to support public policies that are proven to help equitably prevent and detect cancer and prevent people and youth from starting to use tobacco.
More than half of all cancer deaths can be prevented by fully leveraging the knowledge, tools and medical breakthroughs we have today.
Providing everyone with the opportunity to have a healthy lifestyle and access to cancer screenings – like mammograms and colonoscopies – could save thousands of lives every year, and eliminate the inequities that exist in the prevention
and early detection of cancer.
After more than 10 years of delays by Big Tobacco and the U.S. Food and Drug Administration (FDA), legal challenges filed by ACS CAN and our tobacco control partners resulted in two critical components of the Tobacco Control Act moving forward in 2020. Due to our court victories, FDA will review all new tobacco products – including most e-cigarettes, some cigars and smokeless tobacco, and hookah and pipe tobacco – against a standard of appropriate protection of public health, including the risks and benefits to the population as a whole and whether such products would affect tobacco initiation or cessation. The FDA also issued a final rule requiring new graphic warnings on cigarette packages and advertisements outlining their health risks, including the risk of cancer. The graphic warnings rule is being challenged by the tobacco industry in court, and we are now helping FDA defend it.
ACS CAN fought for improved tobacco control measures across the country. Oregonians voted to raise the state’s cigarette tax by $2 per pack and to tax e-cigarettes for the first time in the state. The increase, which went into effect in January 2021, is projected to keep nearly 19,000 kids and young adults from smoking. Illinois doubled its tobacco control funding to a total of $10 million dollars appropriated, while Maine increased tobacco control funding by more than $2 million. ACS CAN and public health allies formed a coalition and successfully encouraged voters to oppose a ballot measure that would have diverted funds away from tobacco prevention and cessation programs that have helped 2.4 million Oklahomans. California passed restrictions on the sale of flavored tobacco, including menthol cigarettes, a critical step forward in our health equity work as the tobacco industry continues to use flavored products to hook and addict youth, low-income communities, LGBTQ+ communities and communities of color.
ACS CAN supported the successful reauthorization of the Early Act, which enables the CDC to increase awareness and education about breast cancer among young women at high risk. The Act also supports efforts to get health care providers information they need to detect early warning signs of breast cancer in younger women. The reauthorization was included as part of an end-of-year spending package passed by Congress in December 2020.
Cancer screening saves lives by detecting disease early when it is easier to treat. ACS CAN successfully advocated to increase or protect funding for early detection programs in several states in 2020.
Minnesota expanded the reach of its breast and cervical cancer early detection programs by creating a pathway to treatment for American Indian women who are diagnosed with breast or cervical cancer.
ACS CAN successfully advocated for passage of the Removing Barriers to Colorectal Cancer Screening Act, which will ensure seniors and others on Medicare have access to colorectal cancer screening without any surprise out-of-pocket costs. A provision phasing in the bill over time was included in the year-end federal funding deal and signed into law by the president. The major bipartisan victory will help improve affordability of lifesaving cancer detection services. ACS CAN volunteers and staff worked tirelessly for the past decade to make this important policy change a reality.
While federal and state laws require health insurance plans to cover colorectal cancer screening starting at age 50, ACS updated its colorectal cancer screening guidelines in 2018 to recommend that screening begin at age 45. This year, the United States Preventive Services Task Force (USPSTF) released updated draft recommendations for colorectal cancer screenings for average-risk populations to align with ACS’ guidelines. If finalized, individuals with ACA-compliant plans will gain access to colorectal cancer screenings without cost sharing starting at age 45. In Indiana, ACS CAN supported successful legislation to require health insurance plans to cover colorectal screening tests beginning at age 45.
1 of 6
2 of 6
3 of 6
4 of 6
5 of 6
6 of 6
Federal Tobacco Regulation
After more than 10 years of delays by Big Tobacco and the U.S. Food and Drug Administration (FDA), legal challenges filed by ACS CAN and our tobacco control partners resulted in two critical components of the Tobacco Control Act moving forward in 2020. Due to our court victories, FDA will review all new tobacco products – including most e-cigarettes, some cigars and smokeless tobacco, and hookah and pipe tobacco – against a standard of appropriate protection of public health, including the risks and benefits to the population as a whole and whether such products would affect tobacco initiation or cessation. The FDA also issued a final rule requiring new graphic warnings on cigarette packages and advertisements outlining their health risks, including the risk of cancer. The graphic warnings rule is being challenged by the tobacco industry in court, and we are now helping FDA defend it.
Reducing Tobacco Use in the States
ACS CAN fought for improved tobacco control measures across the country. Oregonians voted to raise the state’s cigarette tax by $2 per pack and to tax e-cigarettes for the first time in the state. The increase, which went into effect in January 2021, is projected to keep nearly 19,000 kids and young adults from smoking. Illinois doubled its tobacco control funding to a total of $10 million dollars appropriated, while Maine increased tobacco control funding by more than $2 million. ACS CAN and public health allies formed a coalition and successfully encouraged voters to oppose a ballot measure that would have diverted funds away from tobacco prevention and cessation programs that have helped 2.4 million Oklahomans. California passed restrictions on the sale of flavored tobacco, including menthol cigarettes, a critical step forward in our health equity work as the tobacco industry continues to use flavored products to hook and addict youth, low-income communities, LGBTQ+ communities and communities of color.
Breast Cancer Awareness
and Education
ACS CAN supported the successful reauthorization of the Early Act, which enables the CDC to increase awareness and education about breast cancer among young women at high risk. The Act also supports efforts to get health care providers information they need to detect early warning signs of breast cancer in younger women. The reauthorization was included as part of an end-of-year spending package passed by Congress in December 2020.
Increased Funding for Early Detection
Cancer screening saves lives by detecting disease early when it is easier to treat. ACS CAN successfully advocated to increase or protect funding for early detection programs in several states in 2020.
Minnesota expanded the reach of its breast and cervical cancer early detection programs by creating a pathway to treatment for American Indian women who are diagnosed with breast or cervical cancer.
Removing Barriers to Colorectal Cancer Screening
ACS CAN successfully advocated for passage of the Removing Barriers to Colorectal Cancer Screening Act, which will ensure seniors and others on Medicare have access to colorectal cancer screening without any surprise out-of-pocket costs. A provision phasing in the bill over time was included in the year-end federal funding deal and signed into law by the president. The major bipartisan victory will help improve affordability of lifesaving cancer detection services. ACS CAN volunteers and staff worked tirelessly for the past decade to make this important policy change a reality.
Updated Colorectal Cancer
Screening Guidelines
While federal and state laws require health insurance plans to cover colorectal cancer screening starting at age 50, ACS updated its colorectal cancer screening guidelines in 2018 to recommend that screening begin at age 45. This year, the United States Preventive Services Task Force (USPSTF) released updated draft recommendations for colorectal cancer screenings for average-risk populations to align with ACS’ guidelines. If finalized, individuals with ACA-compliant plans will gain access to colorectal cancer screenings without cost sharing starting at age 45. In Indiana, ACS CAN supported successful legislation to require health insurance plans to cover colorectal screening tests beginning at age 45.
Section 1 of 6
Section 2 of 6
Section 3 of 6
Section 4 of 6
Section 5 of 6
Section 6 of 6
ACS CAN works in every state and in Congress to expand access to affordable care for all cancer patients, survivors and those most at risk of the disease.
Access to quality, affordable health care is an essential piece of ACS CAN’s mission to reduce death and suffering from cancer. Research clearly demonstrates that insurance status directly impacts health outcomes, and that those who are insured are diagnosed earlier when cancer is easier and less expensive to treat.
All individuals should have equitable access to quality cancer care. Existing racial and ethnic disparities in cancer care are largely attributed to obstacles accessing health care services, including lack of adequate health insurance coverage.
ACS CAN works in every state and in Congress to expand access to affordable care for all cancer patients, survivors and those most at risk of the disease.
Access to quality, affordable health care is an essential piece of ACS CAN’s mission to reduce death and suffering from cancer. Research clearly demonstrates that insurance status directly impacts health outcomes, and that those who are insured are diagnosed earlier when cancer is easier and less expensive to treat.
All individuals should have equitable access to quality cancer care. Existing racial and ethnic disparities in cancer care are largely attributed to obstacles accessing health care services, including lack of adequate health insurance coverage.
Medicaid Covers US
Launched in 2018, Medicaid Covers US is a national public education project aimed at inviting curiosity, empathy and understanding about the lived experience of individuals, families, organizations and communities impacted by the Medicaid program and the essential role that Medicaid plays in lives of millions of Americans. In 2020, we updated our stories and two documentary films – On the Edge and Critical Condition – to explore the impact of COVID-19 and health disparities on essential workers, rural health care providers and the Black community in Alabama.
Watch Critical Condition: Stories of Health in the Heartland
Watch On the Edge: Health Care in Alabama
Medicaid Covers US
Launched in 2018, Medicaid Covers US is a national public education project aimed at inviting curiosity, empathy and understanding about the lived experience of individuals, families, organizations and communities impacted by the Medicaid program and the essential role that Medicaid plays in lives of millions of Americans. In 2020, we updated our stories and two documentary films – On the Edge and Critical Condition – to explore the impact of COVID-19 and health disparities on essential workers, rural health care providers and the Black community in Alabama.
Watch Critical Condition: Stories of Health in the Heartland
Watch On the Edge: Health Care in Alabama
1 of 7
2 of 7
3 of 7
4 of 7
5 of 7
6 of 7
7 of 7
Public health advocates celebrated two major victories in the fight against cancer in the summer of 2020, when voters in two states supported increased access to health insurance coverage through their respective state Medicaid programs. Oklahomans voted to expand access to health insurance to an estimated 200,000 low-income parents and adults, and Missourians approved Amendment 2, which will provide an estimated 230,000 state residents access to coverage. ACS CAN supported these efforts through grassroots volunteer engagement and media strategies. These wins will improve access to cancer prevention services and help keep rural hospitals open, which is especially critical as the COVID-19 pandemic has exacerbated existing disparities in equitable access to health care in rural communities.
Additionally, the end-of-year Fiscal Year 2021 legislative package included coverage for non-emergency medical transportation for Medicaid recipients, a win in our efforts to improve access to health care for underserved populations.
Many insurance plans have step therapy or “fail first” policies in place that require patients to try less expensive, potentially less effective drugs before the plan will cover the prescriptions their physicians recommend. Not being able to access the treatments they need in a timely manner can lead to worsened symptoms and presents a particular challenge for patients suffering from life-threatening or chronic diseases like cancer. ACS CAN and our volunteers achieved victories in North Carolina and Louisiana this year with signed legislation that will place limits on step therapy policies. These two states join more than 20 others in enacting similar legislation to improve access to care.
Some cancer patients face extremely high out-of-pocket costs for prescription drugs and are forced to go into debt or forgo needed medications because they cannot afford them. ACS CAN, in partnership with many other patient advocacy organizations, advocated to improve affordability at the federal level – launching an ad campaign calling on Congress to remove hurdles to quality cancer care – and in targeted states. New Jersey passed a law that will make it easier for patients who depend on prescription drugs to afford them by requiring insurers to offer at least some plan options that cap patients’ out-of-pocket drug costs at $150 to $250 per prescription, per month starting in 2021. In Maine, ACS CAN supported a package of health care reform bills that will protect patients from surprise medical bills for emergency services and require health insurers to offer a standardized set of health insurance plans, making plans easier to understand and compare.
Congress’ FY 2021 funding deal included the No Surprises Act to prohibit surprise medical billing in most cases, an ACS CAN priority and a significant step in the right direction to reduce surprise out-of-pocket costs for patients. This new law will provide long-needed peace of mind for those trying to afford their care.
ACS CAN filed multiple amicus curiae (“friend of the court”) briefs in 2020 to protect critical access to care. We led 20 patient groups representing millions of Americans with pre-existing conditions in a brief to the U.S. Supreme Court detailing the devastating impact patients would face should the court rule to invalidate the Affordable Care Act (ACA), ensuring the patient voice is heard by the high court. We successfully urged the U.S. Court of Appeals for the District of Columbia to strike down the use of work requirements for Medicaid, which would have caused thousands to be deprived of their health care in Kentucky.
The new Costs of Cancer 2020 report indicates that cancer patient out-of-pocket costs are unaffordable, on the rise and don’t impact all patients equally. This report uses real cost estimates for several types of cancer treatment in various insurance scenarios to illustrate how cost affects access to care and what policymakers can do to ensure that all people with cancer can afford the right care at the right time.
While health insurance is a critical component of access to care, barriers remain – even for the insured. ACS CAN’s 2020 report, The Medicare Appeals Process, highlights the challenges that can stand in the way of quality care for the more than 61 million Americans with Medicare coverage. We found that the appeals process is overly complex, can result in long delays in care, and is not well understood by beneficiaries who may not know their appeal rights. But policymakers can help solve these problems following our recommendations for simplifying and streamlining the process.
Section 1 of 7
Section 2 of 7
Section 3 of 7
Section 4 of 7
Section 5 of 7
Section 6 of 7
Section 7 of 7
Medicaid Expansion
Public health advocates celebrated two major victories in the fight against cancer in the summer of 2020, when voters in two states supported increased access to health insurance coverage through their respective state Medicaid programs. Oklahomans voted to expand access to health insurance to an estimated 200,000 low-income parents and adults, and Missourians approved Amendment 2, which will provide an estimated 230,000 state residents access to coverage. ACS CAN supported these efforts through grassroots volunteer engagement and media strategies. These wins will improve access to cancer prevention services and help keep rural hospitals open, which is especially critical as the COVID-19 pandemic has exacerbated existing disparities in equitable access to health care in rural communities.
Additionally, the end-of-year Fiscal Year 2021 legislative package included coverage for non-emergency medical transportation for Medicaid recipients, a win in our efforts to improve access to health care for underserved populations.
Access to Effective Treatment
Many insurance plans have step therapy or “fail first” policies in place that require patients to try less expensive, potentially less effective drugs before the plan will cover the prescriptions their physicians recommend. Not being able to access the treatments they need in a timely manner can lead to worsened symptoms and presents a particular challenge for patients suffering from life-threatening or chronic diseases like cancer. ACS CAN and our volunteers achieved victories in North Carolina and Louisiana this year with signed legislation that will place limits on step therapy policies. These two states join more than 20 others in enacting similar legislation to improve access to care.
Access to Affordable Treatment
Some cancer patients face extremely high out-of-pocket costs for prescription drugs and are forced to go into debt or forgo needed medications because they cannot afford them. ACS CAN, in partnership with many other patient advocacy organizations, advocated to improve affordability at the federal level – launching an ad campaign calling on Congress to remove hurdles to quality cancer care – and in targeted states. New Jersey passed a law that will make it easier for patients who depend on prescription drugs to afford them by requiring insurers to offer at least some plan options that cap patients’ out-of-pocket drug costs at $150 to $250 per prescription, per month starting in 2021. In Maine, ACS CAN supported a package of health care reform bills that will protect patients from surprise medical bills for emergency services and require health insurers to offer a standardized set of health insurance plans, making plans easier to understand and compare.
Protecting Patients from
Surprise Medical Bills
Congress’ FY 2021 funding deal included the No Surprises Act to prohibit surprise medical billing in most cases, an ACS CAN priority and a significant step in the right direction to reduce surprise out-of-pocket costs for patients. This new law will provide long-needed peace of mind for those trying to afford their care.
Fighting Back Against Access to Care Threats in the Courts
ACS CAN filed multiple amicus curiae (“friend of the court”) briefs in 2020 to protect critical access to care. We led 20 patient groups representing millions of Americans with pre-existing conditions in a brief to the U.S. Supreme Court detailing the devastating impact patients would face should the court rule to invalidate the Affordable Care Act (ACA), ensuring the patient voice is heard by the high court. We successfully urged the U.S. Court of Appeals for the District of Columbia to strike down the use of work requirements for Medicaid, which would have caused thousands to be deprived of their health care in Kentucky.
Costs of Cancer
The new Costs of Cancer 2020 report indicates that cancer patient out-of-pocket costs are unaffordable, on the rise and don’t impact all patients equally. This report uses real cost estimates for several types of cancer treatment in various insurance scenarios to illustrate how cost affects access to care and what policymakers can do to ensure that all people with cancer can afford the right care at the right time.
Medicare Appeals Process
While health insurance is a critical component of access to care, barriers remain – even for the insured. ACS CAN’s 2020 report, The Medicare Appeals Process, highlights the challenges that can stand in the way of quality care for the more than 61 million Americans with Medicare coverage. We found that the appeals process is overly complex, can result in long delays in care, and is not well understood by beneficiaries who may not know their appeal rights. But policymakers can help solve these problems following our recommendations for simplifying and streamlining the process.
Cancer Votes is ACS CAN’s national candidate and voter education campaign through which volunteers from across the country ask political candidates of all parties to make clear their positions on our priority cancer issues.
At the beginning of 2020, ACS CAN volunteers focused their work in the key primary states of Iowa, New Hampshire and South Carolina, getting candidates, including then-presidential candidate Kamala Harris on the record on our issues including protecting people with pre-existing conditions, increasing funding for cancer research and regulating the marketing of e-cigarettes.
ACS CAN staff invited all the presidential candidates, from both sides, to meet with us to discuss cancer issues. Eight campaigns took us up on the offer, including the campaign of then-presidential candidate Joe Biden.
Cancer Votes is ACS CAN’s national candidate and voter education campaign through which volunteers from across the country ask political candidates of all parties to make clear their positions on our priority cancer issues.
At the beginning of 2020, ACS CAN volunteers focused their work in the key primary states of Iowa, New Hampshire and South Carolina, getting candidates, including then-presidential candidate Kamala Harris on the record on our issues including protecting people with
pre-existing conditions, increasing funding for cancer research and regulating the marketing of e-cigarettes.
ACS CAN staff invited all the presidential candidates, from both sides, to meet with us to discuss cancer issues. Eight campaigns took us up on the offer, including the campaign of then-presidential candidate Joe Biden.
Cancer Votes
After the pandemic began, we found innovative ways to remain effective.
Cancer Votes is nonpartisan and does not advocate for any particular candidate or party. Many ACS CAN volunteers, however, are active in a personal capacity in campaigns on both sides. For example, in 2020, Arizona ACT Lead Jeff Jeans was featured on the second night of the Democratic National Convention, talking about how the Affordable Care Act saved his life.
Cancer Votes
After the pandemic began, we found innovative ways to remain effective.
Cancer Votes is nonpartisan and does not advocate for any particular candidate or party. Many ACS CAN volunteers, however, are active in a personal capacity in campaigns on both sides. For example, in 2020, Arizona ACT Lead Jeff Jeans was featured on the second night of the Democratic National Convention, talking about how the Affordable Care Act saved his life.
In the face of ongoing, compounding challenges resulting from the COVID-19 pandemic, ACS CAN advocates never wavered in their pursuit of public policies that will reduce the burden of cancer for patients, survivors and all those at risk of the disease.
Looking forward, in addition to our continued work to remove barriers to adequate, affordable health care and secure robust funding for cancer research and prevention programs, ACS CAN will continue to address the emerging challenges created – and exacerbated by – the pandemic while advancing the fight against cancer in communities nationwide.
In the face of ongoing, compounding challenges resulting from the COVID-19 pandemic, ACS CAN advocates never wavered in their pursuit of public policies that will reduce the burden of cancer for patients, survivors and all those at risk of the disease.
Looking forward, in addition to our continued work to remove barriers to adequate, affordable health care and secure robust funding for cancer research and prevention programs, ACS CAN will continue to address the emerging challenges created – and exacerbated by – the pandemic while advancing the fight against cancer in communities nationwide.
As ACS CAN advocates to eliminate health disparities in cancer, we will continue to support the Health Equity and Accountability Act. This bill puts forth a set of strategic policy solutions designed to eliminate racial and ethnic health disparities; improve data collection and reporting to understand health disparities; monitor progress toward equity goals, diversify the health care workforce and increase diverse participation in clinical trials among underrepresented communities.
ACS CAN has been a leader in the fight to close the gap between the need for palliative care and the number of health professionals equipped to provide it. The COVID-19 pandemic has amplified the need for palliative care services even beyond the existing shortfall. Palliative care is symptom management offered alongside curative care that can be offered at any age or stage of treatment. The Palliative Care and Hospice Education and Training Act (PCHETA), which has passed twice in the House of Representatives, could provide immediate assistance in addressing needs related to COVID-19 as well as long-standing needs in the cancer community.
People who smoke or who smoked previously are at increased risk for severe illness from COVID-19. Regular and significant increases in tobacco taxes are one of the most effective ways to prevent people from using tobacco and encourage current users to quit. Increasing tobacco taxes also generates much-needed revenue for states. Now more than ever, states must do everything in their power to keep our communities healthy and safe. ACS CAN will continue to advocate for increasing taxes on all tobacco products, investing tobacco tax revenue in evidence-based comprehensive tobacco control programs and building strong public health infrastructure and ensuring access to health care.
1 of 3
2 of 3
3 of 3
Health Equity and Accountability
As ACS CAN advocates to eliminate health disparities in cancer, we will continue to support the Health Equity and Accountability Act. This bill puts forth a set of strategic policy solutions designed to eliminate racial and ethnic health disparities; improve data collection and reporting to understand health disparities; monitor progress toward equity goals, diversify the health care workforce and increase diverse participation in clinical trials among underrepresented communities.
Continued Promotion
of Palliative Care
ACS CAN has been a leader in the fight to close the gap between the need for palliative care and the number of health professionals equipped to provide it. The COVID-19 pandemic has amplified the need for palliative care services even beyond the existing shortfall. Palliative care is symptom management offered alongside curative care that can be offered at any age or stage of treatment. The Palliative Care and Hospice Education and Training Act (PCHETA), which has passed twice in the House of Representatives, could provide immediate assistance in addressing needs related to COVID-19 as well as long-standing needs in the cancer community.
Tobacco Taxes
People who smoke or who smoked previously are at increased risk for severe illness from COVID-19. Regular and significant increases in tobacco taxes are one of the most effective ways to prevent people from using tobacco and encourage current users to quit. Increasing tobacco taxes also generates much-needed revenue for states. Now more than ever, states must do everything in their power to keep our communities healthy and safe. ACS CAN will continue to advocate for increasing taxes on all tobacco products, investing tobacco tax revenue in evidence-based comprehensive tobacco control programs and building strong public health infrastructure and ensuring access to health care.
Section 1 of 3
Section 2 of 3
Section 3 of 3
Following are some of the individuals and organizations that helped make 2020 such a successful year for ACS CAN despite the challenges collectively faced by our country.
We also extend a sincere thank you to those not specifically mentioned here, as this list is by no means exhaustive, and to our colleagues to whom we had to bid farewell in 2020. Please know your contributions did not go unnoticed.
Following are some of the individuals and organizations that helped make 2020 such a successful year for ACS CAN despite the challenges collectively faced by our country.
We also extend a sincere thank you to those not specifically mentioned here, as this list is by no means exhaustive, and to our colleagues to whom we had to bid farewell in 2020. Please know your contributions did not go unnoticed.
1 of 4
2 of 4
3 of 4
4 of 4
State Lead Ambassadors
Ambassador Constituent Teams
National Ambassador Team
ACS CAN Staff
American Cancer Society Staff
ACS CAN Board of Directors
Judicial Advocacy Initiative (JAI)
ACS CAN’s efforts are supported by the work of attorneys who donate their time, services and specialized expertise as part of the Judicial Advocacy Initiative to help advance our mission. Thank you to these individuals.
in-kind donors
In light of the significant economic impact the COVID-19 pandemic has had on nonprofit organizations, multiple vendors generously provided in-kind donations of their services to ACS CAN, for which we are very grateful.
ACS CAN recognizes exceptional volunteers, staff members and elected officials throughout our annual Leadership Summit & Lobby Day.
The National Distinguished Advocacy Award (NDAA), which is ACS CAN’s most prestigious advocacy honor, is awarded to public officials for leadership in the mission to end cancer as a public health problem. The 2020 NDAA recipients were:
U.S. Representative Lisa Blunt Rochester (D-DE)
U.S. Representative Brian Fitzpatrick (R-PA)
Massachusetts State Senator John Keenan
Massachusetts State Representative
Danielle Gregoire
Atlanta City Councilmember
Matt Westmoreland
*The Volunteer Award for Excellence in Advocacy, ACS CAN’s highest honor for volunteers, is presented annually to exemplary volunteers in recognition of outstanding leadership and continuous service in the area of advocacy and public policy.
*The Alan Mills Award, ACS CAN’s highest honor for advocacy staff, is presented to the individual who best embodies the passion and dedication of the late Alan Mills, a former American Cancer Society staff lobbyist and one of the founders of the National Government Relations department.
1 of 5
2 of 5
3 of 5
4 of 5
5 of 5
State Lead Ambassadors
Ambassador Constituent Teams
National Ambassador Team
ACS CAN Staff
American Cancer Society Staff
ACS CAN Board of Directors
American Cancer Society Colleges Against Cancer
American Cancer Society Making Strides Against
Breast Cancer
American Cancer Society Relay For Life
The House Cancer Caucus
The Senate Cancer Coalition
Coaches vs. Cancer
Coach Bill Self, University of Kansas
Coach Jay Wright, Villanova University
U.S. Representative Greg Walden (R-OR)
U.S. Representative Colin Allred (D-TX)
Dr. Kimberly Jeffries Leonard,
member of ACS CAN Board of Directors
and president of The Links, Incorporated
Bristol Myers Squibb, Lights of HOPE
presenting sponsor
ACS CAN’s efforts are supported by the work of attorneys who donate their time, services and specialized expertise as part of the Judicial Advocacy Initiative to help advance our mission. Thank you to these individuals.
Melissa Allison
Ken Choe
Allison Cohen
Adam Cooper
Jeffrey Dubner
Ashley Edmonds
Bruce Merlin Fried
Madeline Gittomer
Alyssa Emi Golay
Andrew Goldfarb
Samuel Goldstein
Matthew Higgins
Eve Hill
Lindsay Kaplan
Katherine Kwong
Scott Lewis
Seth Lloyd
John Longstreth
Sean Marotta
Christina Marshall
William O’Brien
Joseph Palmore
Beth Petronio
Claire Pipenburg
Cybil Roehrenbeck
Emanuel Rouvelas
Jessica Wall
Tesch West
In light of the significant economic impact the COVID-19 pandemic has had on nonprofit organizations, multiple vendors generously provided in-kind donations of their services to ACS CAN, for which we are very grateful.
AdvocacySmiths
Betty & Smith
DeMenna Public Affairs
GMMB
Hickey & Associates
Perry Undem, LLC
Phone2Action
Reid, McNally & Savage
Riley, Pope, and Laney, LLC –
Government Relations Team
Subject Matter
Tarplin, Downs & Young, LLC
The Alliance Group
The Campaign Workshop
The Communication Center
Winning Connections
2020 Advocacy Award Recipients
ACS CAN recognizes exceptional volunteers, staff members and elected officials throughout our annual Leadership Summit & Lobby Day.
The National Distinguished Advocacy Award (NDAA), which is ACS CAN’s most prestigious advocacy honor, is awarded to public officials for leadership in the mission to end cancer as a public health problem.
The 2020 NDAA recipients were:
U.S. Representative Lisa Blunt Rochester (D-DE)
U.S. Representative Brian Fitzpatrick (R-PA)
Massachusetts State Senator John Keenan
Massachusetts State Representative Danielle Gregoire
Atlanta City Councilmember Matt Westmoreland
Volunteer Award for Excellence in Advocacy*:
Donna Lundy, Florida
State Lead Ambassador of the Year:
Kathy Ottele, Oregon
John Tramontin, North Carolina
Ambassador Constituent Team Leads of the Year:
Barbara Effman, Florida
Lori Garcia, California
Monica Theis, Minnesota
Emerging Leader:
Victoria Crocker, Georgia
State Advocacy Team of the Year:
Massachusetts
Judicial Advocacy Initiative:
Jeff Dubner, Democracy Forward Foundation
*The Volunteer Award for Excellence in Advocacy, ACS CAN’s highest honor for volunteers, is presented annually to exemplary volunteers in recognition of outstanding leadership and continuous service in the area of advocacy and public policy.
Field Government Relations Professional of the Year:
Kristin Page-Nei, Montana Government
Relations Director
Field Grassroots Professional of the Year:
Paula Warlick, Oklahoma Grassroots Manager
American Cancer Society Partner of the Year:
Tawana Thomas-Johnson, Vice President,
Diversity and Inclusion
Regional Professional of the Year:
Lori Davies, Director, Grassroots Organizing
Alan Mills Award*:
Mary Rouvelas, Senior Counsel
*The Alan Mills Award, ACS CAN’s highest honor for advocacy staff, is presented to the individual who best embodies the passion and dedication of the late Alan Mills, a former American Cancer Society staff lobbyist and one of the founders of the National Government Relations department.
ACS CAN Donors
*Contributor to the campaign opposing Oklahoma State Question 814, in defense of the Tobacco Settlement Endowment Trust, cancer research and tobacco cessation programs
Judicial Advocacy Initiative Contributing Law Firms
Anderson & Kreiger
Brown Goldstein Levy
Dentons
Eversheds Sutherland
K&L Gates
Hogan Lovells
Kilpatrick Townsend
Morrison & Foerster LLP
Polsinelli
Zuckerman Spaeder
Corporate Champions
Amgen
AstraZeneca
Bristol Myers Squibb
EMD Serono
Exact Sciences
Genentech
GlaxoSmithKline
GRAIL
Janssen Oncology
Merck & Co.
Novartis
Pfizer
PhRMA
Regeneron
Sanofi
Corporate Allies
AbbVie
Bayer
Eli Lilly and Company
Exelixis
Foundation Medicine
Hologic
Takeda
Corporate Heroes
Biotechnology Innovation Organization
Boehringer Ingelheim
Eisai
Families USA Foundation
Fight Colorectal Cancer, Inc.
Gilead Sciences
Lyft
Sandoz
Seattle Cancer Care Alliance
Servier
Viatris
Corporate Friends
AARP
Alexandria Real Estate Equities
Association for Accessible Medicines
Astellas
Avera Health
BioReference Laboratories
Boston Children’s Hospital
Cedars-Sinai Cancer
CRISPR Therapeutics
Daiichi Sankyo, Inc.
Dana-Farber Cancer Institute
Fred Hutchinson Cancer Research Center
Guardant Health
Health Care Service Corporation
Highmark Blue Cross Blue Shield
and Allegheny Health Network
Illumina
ImmunoGen
Incyte
Inova
Lungevity Foundation
Myriad Genetics
Penn Quarter Partners
Riley, Pope, and Laney, LLC –
Government Relations Team
Sanford Health
Seagen
Swedish Cancer Institute
Syneos Health
Taiho Oncology
United States Pharmacopeia
University of Arizona Cancer Center –
Dignity Health
Corporate Sponsors
Adaptive Biotechnologies
Alkermes
The Alliance Group
Amica
Association of Northern California Oncologists
Autolus
Beth Israel Deaconess Medical Center
Blue Cross Blue Shield of Alabama
Blueprint Medicines
DeMenna Public Affairs
EQRx
Flatiron Health
Grady Health System
Harvard Medical School
HCA East Florida: Broward Market Hospitals
Hickey & Associates
Idaho Society of Clinical Oncology
Illinois Medical Oncology Society
Intuitive Surgical
Ipsen
Jackson Laboratory
Massachusetts General Hospital Cancer Center
Medical College of Wisconsin Cancer Center
Miami Cancer Institute
Moffitt Cancer Center Malignant Hematology & Cellular Therapy at Memorial Healthcare System
MorphoSys US
Oregon Association of Hospitals & Health Systems
Oregon Oncology Specialists
PacificSource Health Plans
Pannone Lopes Devereaux & O’Gara, LLC
PAREXEL
Rainbolt Family Foundation*
Roche Diagnostics
Salem Health Hospitals and Clinics
SmithGroup
Society of Utah Medical Oncologists
TD Bank
Tonkin Torp LLP
UCLA Health
UnitedHealthcare
University Health System
University of Virginia Cancer Center
We Work for Health
WuXi AppTec
WuXi Biologics
Chair’s Circle
Richard L. Deming, MD
Dr. Douglas Kelsey
Maureen Mann
Omar Rashid, MD, JD
Gary & Cindy Reedy
Michael Shult
Dr. Bruce Waldholtz
President’s Circle
AdventHealth Orlando
Alira Health
James & Kathleen Bond
Boston Biomedical
Boston University
Marissa Brown
Sandra Cassese
Cassia County Fair Board
Cataldo Ambulance Service
P. Kay Coleman
Empire Health Foundation
Dr. Elizabeth Fontham
Dr. Mark Goldberg &
Dr. Ursula Kaiser
Christopher Hansen
Hodes and Landy
Bernard Jackvony
Kris Kim
Jim Knox
Mr. & Mrs. Robert Kugler
Grace Kurak
Michael Kurak
Lisa Lacasse & Bruce Lesley
Scott & Mary Lippman
Dr. Donna Lundy
John Manna Jr.
Sara Mannetter
Michael Marquardt
Massachusetts Society of Clinical Oncolgists
Dr. Karen Moffitt
Scarlott Mueller
Nevada Oncology Society
Northwell Health System
Philip R. O’Brien
OU Medical Center
Perkins Eastman
Providence Health & Services
Jose Ramos Jr.
Emanuel & Marilyn Rouvelas
Mary Rouvelas
Dr. Christy Russell
Peter Sheldon
Daniel Smith
Carter Steger
Gary & Susan Streit
Thermo Fisher Scientific
Dr. & Mrs. Alan Thorson
Pam Traxel
Tufts Medical Center
William Underriner
Dr. Shalini Vallabhan
Robert Youle
Champion’s Circle
Abramson Cancer Center of the University of Pennsylvania
Christopher Aherne
Alaska State Hospital and Nursing Home Association
American Oncology Management Company, LLC
Arthur J Gallagher & Co.
Ashling Partners
Bank of Rhode Island
Dr. Arnie Baskies
Beacon Mutual Insurance Company
Barbara Behal
Benefis Health System
Michael Berman
Jocelyn Bernson
Betty & Smith
Blackbaud
Blue Cross & Blue Shield
of Rhode Island
Blue Cross Blue Shield of Montana
Blue Cross of Idaho
Bonaventure Senior Living
Kathy Bonnette
Bozeman Health
Broward Regional Health Planning Council, Inc.
California Life Sciences Association
Ann Camden
Cancer Insight, LLC
CareOregon
Eugene Carlino
CARTI Little Rock
Castle Biosciences
CG Life
Charlotte Radiology
Hillary Clarke
Clinical Trials Education Network of Wisconsin
Coast Realty Management LLC
Brian Cohen
Community Care Network of Kansas
Community Medical Center
Consolidated Concrete Corp.
Cornerstone Government Affairs
Dr. Ed Coulter
Covering Kids & Families Indiana
Dr. Kevin Cullen
Kathy Cupp
Rodger Currie
CVS Health
Norman Davis
Diana Diaz
Barbara Diver
Dominion Diagnostics
James Dubin
Denis Ducey
Christy Everest*
Jeffrey Fehlis
First Western Bank & Trust
Maggie Fitzpatrick
Dr. Mark Fleury
Florida Cancer Specialists
Dr. Lewis Foxhall
Daniel Glickman
Global Resources International, Inc.
GMMB
Rebecca Greene
Peter Gross
Leslie Sue Healey*
Champion’s Circle (Continued)
Dr. Enrique Hernandez
John Herting
Michael Holtz
Hovland Rasmus Brendtro & Trzynka
Stephen Howell
Paul Hull
Dr. Barry Hummel Jr.
Idaho Power Company and IDACORP
Indiana Oncology Society
Indiana University Health
Iowa Oncology Society
Mike Kahoe
Kansas Hospital Association
Mel Katz
Keesler Federal Credit Union
Kentucky Society
of Clinical Oncology
Dr. Michael Kinch
Marianne Kipper
Landmark Medical Center
Cynthia LeBlanc
Kimberly Lindgren
Loftus Family Foundation
Thomas Long
Magnolia Health Plan
Rebecca Mannel*
Robert Mannel*
Vince Marchetta
Jeffrey Martin
Mayo Clinic Cancer Center
Melissa McLain
Medical Alley Association
Frank Merrick*
Methodist Healthcare Ministries
Miami Beach Community
Health Center
Minnesota Council of Health Plans
Mississippi Association
of Health Plans
Mississippi Hospital Association
Montana’s Credit Unions
Mount Sinai Health System
Mount Sinai School of Medicine
Mountain-Pacific Quality Health Foundation
James Murray
N & M Restaurants
Navigant Credit Union
Nebraska Medical Association
Neighborhood Health Plan
of Rhode Island
New England Laborers’ Health
& Safety Fund
New England Laborers’ Labor Management Cooperation Trust
Nova Southeastern University
Novo Nordisk, Inc.
Nucor Employee’s Credit Union
Olson Remcho
Oregon Nurses Association
OS Studios
Pampered Chef
Peace Health
Perry Undem, LLC
Timothy Phillips
Dr. William Pierce
Dr. Marcus Plescia
Erin Polak
Champion’s Circle (Continued)
Alice Pomponio
Property Advisory Group, Inc.
Providence Auto Body
Lois Raboin Conn
Dr. Ujwala Rajgopal
RALI
Katie Riley
Kimberly Rogers
Roper St. Francis Healthcare
Jeffrey Schultz
SCL Health
Scripps Health
Evan Segal
Linda Shaner
Brian Silverberg
Kirsten Sloan
South Dakota Biotech
Southern New England Windows
Betty Sparrow
St. Luke’s Health System
Paul Stadfeld
State of South Carolina
Dr. Tracey Stokes
Subject Matter
Sunovion
Surescripts
Dr. Eric Taylor
The Seyboth Team
Thomas Jefferson University
Sariah Toronto
Trinity Health
Julie Turner
William Twomey
UC San Diego Moores Cancer Center
UCHealth
UNC Lineberger Comprehensive Cancer Center
Underriner Honda
University of Chicago
University of Chicago Medicine
University of Colorado Cancer Center
University of Illinois Chicago
University of Kansas Health System
Micah Volmer
Amanda Walker
Levi Wallace
Washington State Medical Association
Washington Trust Company
Stephanie Winn
WJAR-NBC10
WVU Cancer Institute
George Young
Ray Young
ZRG Partners
Hero’s Circle
Josie Abboud
Terry Acayan
Omair Ahmed
Albritton Funeral Directors, Inc.
John Alfonso
American Society
of Clinical Oncology
Austin Liquors
Anita Bales
Christopher Banaszak
Barbara Ann Karmanos
Cancer Institute
Joseph Barbetta
Lynda Barbour
Jeffrey Bennett
Bernstein Shur
Billings Clinic
Bioscience Association of Maine
Catherine Blackstone
Jodi Blakley
David Bonfilio
Tamara Boyazis
Dr. William Boykin Jr.
Lori Bremner
BRIX Real Estate, SpaceSource Team
Joy Burks
Judith Calhoun
Grace Camden
Dr. Constance Carroll
Cary Medical Center
Christine Chessen
Choctaw Nation of Oklahoma
Janice Chow-Ng
Christian World Missions
Drew Clawson
Carolyn Coatoam
Lauren Coatoam
Colonial Materials, Inc.
Steven Crawford*
Alissa Crispino
Crowley Fleck PLLP Attorneys
Judy Dagostino
Linda Daschle
Ann Deshler
Cynthia Dickson
Michael Digiano
Neil Eisenberg
Christine Falvello
Margaret Fischbach
Patrick Flinn
Tom Flookes
Cary Franklin
Denise Fridl
David Glidden
Rachel Gomez
James Gray
Green Acres Landscape
Elizabeth Gundersen
Brian Gutierrez
Kathi Hansen
Jan Hardin
Trista Hargrove
Jennifer Hawks Bland
Shannon Haynes
Rick Hazard
Daniel Heist
Robert Henkle
Amber Herting
Jean Holec
Hero’s Circle (Continued)
Eunice Hostetter
Kelly Howley
Kevin Howley
Brian Hummell
John Hussar
Kim Isenberg
Stephen Jackson
Martha Jenkins
Chad Jira
Beth Johnson
Bryte Johnson Jr.
Mary Johnson
Jonathon Hoff Family Memorial
Kalispell Regional Medical Center
Kay Kamm
Linda Karin
Karen Kay
Casey Killblane*
David Kubinski
Christopher Kush
Cynthia Lacasse
Deborah Laclair
Lahey Hospital & Medical Center
Liz Legg
Lehrer Cumming
Sophy Mangana
David Mann
Jeannine Marks
Kathy Ann Martin
Bonnie May
McClain Resort
James McKeogh
Katherine Miceli
Philip Moilanen
Montana Association
of Health Care Purchasers
Montana Dental Association
Linda Montfort
Rosemary Moore
F. Leonard Morris Jr.
John Mossberg
Mountain Health CO-OP
Brad Mumau
Robert Nance*
Dr. Laura Nathan
Diana Navarre
Maysarih Ndobe
Michael Neal
Nickles Bakery
Pam Niese
Dr. Jesse Nodora
Northcross Group
Gary Offerdahl
Albert Orr III
P & K Farms
Stephanie Patrick
C.B. Pearson
Kassy Perry
Jordan Poyer
Gary Premier
Paula Ragan
Reach Beyond Solutions
Susan Regier*
Michael Reich
Kael Reicin
Hugo Ricci
Robert Boissoneault
Oncology Institute
Tyler Rockers
Rockland Trust
Patsy Romero
Judy Rospenda
Hero’s Circle (Continued)
Bernice Sanders
Elizabeth Sanderson
Tara Scott
Michael Semenza
Cynthia Serna
SERVPRO of Mankato/Owatonna
Sevenson Environmental
Services, Inc.
Beth Shissler
Peggy Silbert
Kim Smarsh
Neal Spencer
Spiegel’s South Shore Scrap Metal
Amanda Stanton
Team Steadman
Erica Storm
Eugene Stuart
TJ Sullivan
Tennessee School of Beauty
Lu-Shawn Thompson
Glenn Tilton
Jacqueline Tilton
Jennifer True
Lee Turner
Twelve Pins Chicago, Inc.
Nevette Tyus-Middleton
University of Kansas Cancer Center
Valley Credit Union
Heidi Varner
Rajeev Vasudeva
Veritas Advisors LLP
Walmart
Walmart Foundation
Gina Walsh
Teresa Warnock
West Virginia University
Ann Wheet
Wolfe County Farm Bureau Insurance
Dick Woodruff
Lisa Worthington
Z Global, Inc.
Leader’s Circle
Paul Adam
Zeke Aguilera
Kathy Aherne
Applebee’s
Michelle Appleby
Patty Avery
Dr. Lisa Bailey
Caroline Baker
Mark Bamforth
Lance Barbour
Shelly Barsanti
Carol Becker
Cindy Bedford
David Benson
Amy Bianchino
Doug Bland
Sam Blankenship
Michele Bloch
Michael Bogen
Carrie Boston
Karin Boyte Thompsen
Virginia Brase
Andrea Britcher
Terrance Britt
Scott Brock
Patricia Brown
Bulas Antiques and Collectibles, LLC
Denise Burns
Grant Cale
Jackie Cale
Cathryn Callaway
Anthony Calvelage
Mark Cameli
Frank Cardinal III
Linda Carlson
Pearl Carter
Luke Cavener
Elisheva Chamblin
Sharon Chicano
Ben Choice
Jody Clark
Janet Clearwater
Tiffany Cloud
Margaret Coffey
Rick Cole
Karen Connor
Jennifer Coston
JoAnne Cousino
Roger Crawford
Cross Mahoney Living Trust
Rossana Cuellar
Scott Cushing
Dacey Insurance Agency, Inc.
Marie-Michele Darcy
Lori Davies
Dimple Davis
Xavier Decaire
Linda DeGarmo
Judy Delfabro
Sarah Domm
Richard Douglas
Lori Drew
Sharon Dymnioski
Karen Dziedzic
Denice Economou
Mavis Edme
Rachael Eerdmans
Don Enslow
Damian Eonta
Melissa Erickson
Glenn Eyrich
Falvello Law Firm
Leader’s Circle (Continued)
Amy Farner
Jeffrey Feldman
Stephen Fetzer
Suzanne Fink
First Baptist Church Fannin
Kathy Flaherty
Joann Flegel
Nathan Forrester
Maryjo Foseid
Elaine Franco
Marlene Fraser
Nancy Freeman
Friends of John Shott 2018
Lori Garcia
Gastroenterology Specialties, P.C.
Allen Gee
Sandra Geroux
Jeff Gillis
Miles Goda
Scott Goodlin
Bernard Goulding Jr.
Gould’s Supermarket, Inc.
Dr. Bobby Graham Jr.
Kay Graven
Kimberly Green
Kerry Grisolano
Jamie Gross
Gregg Haifley
Heather Hall
Marcus Hall
Meloni Hallock
Ken Hamm
Richard Harkess
Stacey Harmon-Roeber
Robert Harris
Julianne Hart
Jill Haupt
Todd Hauptli
Patricia Heaston
Ruth Heineman
Tad Heitmann
Deanna Henkle
Sean Hennen
Edith Hitchings
John Hoctor
Linda Holden
Gloria Holtz
Jacqueline Hoskins
Rosilyn Houston
Dr. Esther Jacobs
The John Lewis Family
Robert Johnson Jr.
Mary Jones
Patricia Jury
William Kelly
George Kendall
Sally Kennedy
Kelly Kenyon
Kent Kepler
Allen Kessler
Travis Ketterman
Rani Khetarpal
Patrick Killen
Riguey King
Sherwood Kingsley
Kristopher Kipp
Kerstin Kirchner
Mary Ann Klefisch
Patricia Knight
Eric Konigsberg
Karl Kruger
Heidi LaBree
Leader’s Circle (Continued)
Marc Lacasse
Anita Lambert
Crystal Landavazo
Teresa Lane
Dr. Walter Lawrence Jr.
Rose Marie Layman
Lyndia Lewis
Scott Lewis
David Light
Elizabeth Lippman
Joe Loughrey
Luce Research
Mark Lundy
Donna Lutke
J.P. Mann
Malcolm Manwell
Joe Marchetta
Andrea Marks
Carla Martin
Elizabeth Martin
Lori Martin
Amy Martinez
Auda Martinez
Percy Martinez
Ann Massey
Janet Mata
Charles Matthau
Mayo High School Football
Hall of Fame
Ashley McAuley
Kristen McEnroe
Colleen McGuire Schmitz
Stephen Medlin
Fred Meng
James Midtlien
Ellen Miller
Katharine Miller
Earl Minnis
Libby Mongue-Wymore
Colten Moore
Moose Ridge Associates
Blythe Moran
Arden Morris
Cheri Morrison
Jamey Mosley
Mother Stewarts Brewing Co., LLC
Linda Muccitelli
Music in the Park Fund
Emily Myatt
Nancy Neel
Louise Neiterman
Debra Nevels
Charles Nichols
Bryan Noble
Northstar Grill
Gail Nyari-Lazzaro
Rebecca Oechsner
Kathleen Ottele
Ronald Ours III
Jeffrey Pace
Diana Page
Jean Paul
Dr. Susan Perlman
Lynne Peters
Terrell Philen Jr.
Johnny Phillips
Tyler Piekarski
Pamela Pilgrim
Leader’s Circle (Continued)
Kathryn Powell
Robert Prieto
Professionals Plus Realty, Inc.
Matt Prokop
David Pugach
Grace Pugh
Usha Raju
Lois Ramer
Sara Ramos
Donna Rennick
Renee Rettig
Andrea Ridenour
Hubert Riley
Theodore Riley Jr.
L. Scott Ritterbush
River Terrace Rehab
& Healthcare Center
RMGY, Inc.
Catherine Roberts
Donna Roberts
Michael Rodriquez
David Rogers
Jitesh Rohatgi
Denise Romand
Duane Ross
Jenell Ross
Helaine Rothman
Gregg Rothschild
Teresa Rutherford
Alison Sachs
Sanderjian Therapies
Dr. Carmen Sato-Bigbee
Dr. Charles Saxe III
Christine Schaub
Robert Schechner
Zachary Schlagel
Danielle Scholz
Peter Sedlak
Jon Sexton
Shady Lane, Inc.
Lorraine Shalvoy
Karyn Shatzman
Jacky Sher Raker
Sylvia Sherman
William Sherman II
Lindsi Shrock
Rose Shulgay
Marlene Sincaglia
Lana Skirboll
Robert Soles
Richard Soll
Southworth-Milton
Gwen Spencer
Matt Spiegel
Ann Stangl
Citseko Staples Miller
Eric Stern
Stoddard American Legion
Post 315, Inc.
Noe Streetman
Jane Streets
Diana Sulewski
Ronald Sulewski
Angela Sylling
Joyce Thibodeaux
Leon Thomas
Thompson Cancer Survival Center
Allison Thomson
Leader’s Circle (Continued)
Jeanne Thornhill
William Tobin
Barbie Todd
Toma for City Council
King Boyz Towing
John Tramontin
Beth Trierweiler
Stephen Tyrrell
Carol Van Hal Browne
Theresa Vawter
Katherine Vogt
Gerald Wages
Wayne Wallingford Jr.
Pamela Warshavsky
Ursula Webster
Harry Werlin
Mary Weyant
Dr. Richard White Jr.
Tony Williams
Carolyn Williams-Goldman
Scott Williford
Sylvia Wolf
Gordon Wright
Julie Wrigley
John Yadlosky
Greg Yoshii
Claudia Young
Michelle Zornes
1 of 15
2 of 15
3 of 15
4 of 15
5 of 15
6 of 15
7 of 15
8 of 15
9 of 15
10 of 15
11 of 15
12 of 15
13 of 15
14 of 15
15 of 15
ACS CAN Donors
Anderson & Kreiger
Brown Goldstein Levy
Dentons
Eversheds Sutherland
K&L Gates
Hogan Lovells
Kilpatrick Townsend
Morrison & Foerster LLP
Polsinelli
Zuckerman Spaeder
Amgen
AstraZeneca
Bristol Myers Squibb
EMD Serono
Exact Sciences
Genentech
GlaxoSmithKline
GRAIL
Janssen Oncology
Merck & Co.
Novartis
Pfizer
PhRMA
Regeneron
Sanofi
AbbVie
Bayer
Eli Lilly and Company
Exelixis
Foundation Medicine
Hologic
Takeda
Biotechnology Innovation Organization
Boehringer Ingelheim
Eisai
Families USA Foundation
Fight Colorectal
Cancer, Inc.
Gilead Sciences
Lyft
Sandoz
Seattle Cancer Care Alliance
Servier
Viatris
AARP
Alexandria Real Estate Equities
Association for
Accessible Medicines
Astellas
Avera Health
BioReference Laboratories
Boston Children’s Hospital
Cedars-Sinai Cancer
CRISPR Therapeutics
Daiichi Sankyo, Inc.
Dana-Farber
Cancer Institute
Fred Hutchinson Cancer Research Center
Guardant Health
Health Care Service Corporation
Highmark Blue Cross Blue Shield and Allegheny Health Network
Illumina
ImmunoGen
Incyte
Inova
Lungevity Foundation
Myriad Genetics
Penn Quarter Partners
Riley, Pope, and
Laney, LLC –
Government
Relations Team
Sanford Health
Seagen
Swedish Cancer Institute
Syneos Health
Taiho Oncology
United States Pharmacopeia
University of Arizona
Cancer Center –
Dignity Health
Adaptive Biotechnologies
Alkermes
The Alliance Group
Amica
Association of Northern California Oncologists
Autolus
Beth Israel Deaconess Medical Center
Blue Cross Blue Shield of Alabama
Blueprint Medicines
DeMenna Public Affairs
EQRx
Flatiron Health
Grady Health System
Harvard Medical School
HCA East Florida: Broward Market Hospitals
Hickey & Associates
Idaho Society of Clinical Oncology
Illinois Medical Oncology Society
Intuitive Surgical
Ipsen
Jackson Laboratory
Massachusetts General Hospital Cancer Center
Medical College of Wisconsin Cancer Center
Miami Cancer Institute
Moffitt Cancer Center Malignant Hematology & Cellular Therapy at Memorial Healthcare System
MorphoSys US
Oregon Association of Hospitals & Health Systems
Oregon Oncology Specialists
PacificSource Health Plans
Pannone Lopes Devereaux & O’Gara, LLC
PAREXEL
Rainbolt Family Foundation*
Roche Diagnostics
Salem Health Hospitals and Clinics
SmithGroup
Society of Utah Medical Oncologists
TD Bank
Tonkin Torp LLP
UCLA Health
UnitedHealthcare
University Health System
University of Virginia Cancer Center
We Work for Health
WuXi AppTec
WuXi Biologics
Richard L. Deming, MD
Dr. Douglas Kelsey
Maureen Mann
Omar Rashid, MD, JD
Gary & Cindy Reedy
Michael Shult
Dr. Bruce Waldholtz
AdventHealth Orlando
Alira Health
James & Kathleen Bond
Boston Biomedical
Boston University
Marissa Brown
Sandra Cassese
Cassia County Fair Board
Cataldo Ambulance Service
P. Kay Coleman
Empire Health Foundation
Dr. Elizabeth Fontham
Dr. Mark Goldberg &
Dr. Ursula Kaiser
Christopher Hansen
Hodes and Landy
Bernard Jackvony
Kris Kim
Jim Knox
Mr. & Mrs. Robert Kugler
Grace Kurak
Michael Kurak
Lisa Lacasse & Bruce Lesley
Scott & Mary Lippman
Dr. Donna Lundy
John Manna Jr.
Sara Mannetter
Michael Marquardt
Massachusetts Society
of Clinical Oncolgists
Dr. Karen Moffitt
Scarlott Mueller
Nevada Oncology Society
Northwell Health System
Philip R. O’Brien
OU Medical Center
Perkins Eastman
Providence Health & Services
Jose Ramos Jr.
Emanuel & Marilyn Rouvelas
Mary Rouvelas
Dr. Christy Russell
Peter Sheldon
Daniel Smith
Carter Steger
Gary & Susan Streit
Thermo Fisher Scientific
Dr. & Mrs. Alan Thorson
Pam Traxel
Tufts Medical Center
William Underriner
Dr. Shalini Vallabhan
Robert Youle
Abramson Cancer Center of the University of Pennsylvania
Christopher Aherne
Alaska State Hospital and Nursing Home Association
American Oncology Management
Company, LLC
Arthur J Gallagher & Co.
Ashling Partners
Bank of Rhode Island
Dr. Arnie Baskies
Beacon Mutual
Insurance Company
Barbara Behal
Benefis Health System
Michael Berman
Jocelyn Bernson
Betty & Smith
Blackbaud
Blue Cross & Blue Shield of Rhode Island
Blue Cross Blue Shield
of Montana
Blue Cross of Idaho
Bonaventure Senior Living
Kathy Bonnette
Bozeman Health
Broward Regional Health Planning Council, Inc.
California Life Sciences Association
Ann Camden
Cancer Insight, LLC
CareOregon
Eugene Carlino
CARTI Little Rock
Castle Biosciences
CG Life
Charlotte Radiology
Hillary Clarke
Clinical Trials Education Network of Wisconsin
Coast Realty
Management LLC
Brian Cohen
Community Care
Network of Kansas
Community Medical Center
Consolidated
Concrete Corp.
Cornerstone
Government Affairs
Dr. Ed Coulter
Covering Kids &
Families Indiana
Dr. Kevin Cullen
Kathy Cupp
Rodger Currie
CVS Health
Norman Davis
Diana Diaz
Barbara Diver
Dominion Diagnostics
James Dubin
Denis Ducey
Christy Everest*
Jeffrey Fehlis
First Western Bank & Trust
Maggie Fitzpatrick
Dr. Mark Fleury
Florida Cancer Specialists
Dr. Lewis Foxhall
Daniel Glickman
Global Resources International, Inc.
GMMB
Rebecca Greene
Peter Gross
Leslie Sue Healey*
Dr. Enrique Hernandez
John Herting
Michael Holtz
Hovland Rasmus
Brendtro & Trzynka
Stephen Howell
Paul Hull
Dr. Barry Hummel Jr.
Idaho Power Company and IDACORP
Indiana Oncology Society
Indiana University Health
Iowa Oncology Society
Mike Kahoe
Kansas Hospital Association
Mel Katz
Keesler Federal Credit Union
Kentucky Society of Clinical Oncology
Dr. Michael Kinch
Marianne Kipper
Landmark Medical Center
Cynthia LeBlanc
Kimberly Lindgren
Loftus Family Foundation
Thomas Long
Magnolia Health Plan
Rebecca Mannel*
Robert Mannel*
Vince Marchetta
Jeffrey Martin
Mayo Clinic Cancer Center
Melissa McLain
Medical Alley Association
Frank Merrick*
Methodist Healthcare Ministries
Miami Beach Community Health Center
Minnesota Council of Health Plans
Mississippi Association
of Health Plans
Mississippi Hospital Association
Montana’s Credit Unions
Mount Sinai
Health System
Mount Sinai School
of Medicine
Mountain-Pacific Quality Health Foundation
James Murray
N & M Restaurants
Navigant Credit Union
Nebraska Medical Association
Neighborhood Health Plan of Rhode Island
New England Laborers’ Health & Safety Fund
New England Laborers’ Labor Management Cooperation Trust
Nova Southeastern University
Novo Nordisk, Inc.
Nucor Employee’s
Credit Union
Olson Remcho
Oregon Nurses Association
OS Studios
Pampered Chef
Peace Health
Perry Undem, LLC
Timothy Phillips
Dr. William Pierce
Dr. Marcus Plescia
Erin Polak
Alice Pomponio
Property Advisory Group, Inc.
Providence Auto Body
Lois Raboin Conn
Dr. Ujwala Rajgopal
RALI
Katie Riley
Kimberly Rogers
Roper St. Francis Healthcare
Jeffrey Schultz
SCL Health
Scripps Health
Evan Segal
Linda Shaner
Brian Silverberg
Kirsten Sloan
South Dakota Biotech
Southern New England Windows
Betty Sparrow
St. Luke’s Health System
Paul Stadfeld
State of South Carolina
Dr. Tracey Stokes
Subject Matter
Sunovion
Surescripts
Dr. Eric Taylor
The Seyboth Team
Thomas Jefferson University
Sariah Toronto
Trinity Health
Julie Turner
William Twomey
UC San Diego Moores Cancer Center
UCHealth
UNC Lineberger Comprehensive Cancer Center
Underriner Honda
University of Chicago
University of Chicago Medicine
University of Colorado Cancer Center
University of Illinois Chicago
University of Kansas Health System
Micah Volmer
Amanda Walker
Levi Wallace
Washington State
Medical Association
Washington Trust Company
Stephanie Winn
WJAR-NBC10
WVU Cancer Institute
George Young
Ray Young
ZRG Partners
Josie Abboud
Terry Acayan
Omair Ahmed
Albritton Funeral Directors, Inc.
John Alfonso
American Society of Clinical Oncology
Austin Liquors
Anita Bales
Christopher Banaszak
Barbara Ann Karmanos Cancer Institute
Joseph Barbetta
Lynda Barbour
Jeffrey Bennett
Bernstein Shur
Billings Clinic
Bioscience Association
of Maine
Catherine Blackstone
Jodi Blakley
David Bonfilio
Tamara Boyazis
Dr. William Boykin Jr.
Lori Bremner
BRIX Real Estate, SpaceSource Team
Joy Burks
Judith Calhoun
Grace Camden
Dr. Constance Carroll
Cary Medical Center
Christine Chessen
Choctaw Nation
of Oklahoma
Janice Chow-Ng
Christian World Missions
Drew Clawson
Carolyn Coatoam
Lauren Coatoam
Colonial Materials, Inc.
Steven Crawford*
Alissa Crispino
Crowley Fleck PLLP
Attorneys
Judy Dagostino
Linda Daschle
Ann Deshler
Cynthia Dickson
Michael Digiano
Neil Eisenberg
Christine Falvello
Margaret Fischbach
Patrick Flinn
Tom Flookes
Cary Franklin
Denise Fridl
David Glidden
Rachel Gomez
James Gray
Green Acres Landscape
Elizabeth Gundersen
Brian Gutierrez
Kathi Hansen
Jan Hardin
Trista Hargrove
Jennifer Hawks Bland
Shannon Haynes
Rick Hazard
Daniel Heist
Robert Henkle
Amber Herting
Jean Holec
Eunice Hostetter
Kelly Howley
Kevin Howley
Brian Hummell
John Hussar
Kim Isenberg
Stephen Jackson
Martha Jenkins
Chad Jira
Beth Johnson
Bryte Johnson Jr.
Mary Johnson
Jonathon Hoff Family Memorial
Kalispell Regional
Medical Center
Kay Kamm
Linda Karin
Karen Kay
Casey Killblane*
David Kubinski
Christopher Kush
Cynthia Lacasse
Deborah Laclair
Lahey Hospital &
Medical Center
Liz Legg
Lehrer Cumming
Sophy Mangana
David Mann
Jeannine Marks
Kathy Ann Martin
Bonnie May
McClain Resort
James McKeogh
Katherine Miceli
Philip Moilanen
Montana Association of Health Care Purchasers
Montana Dental Association
Linda Montfort
Rosemary Moore
F. Leonard Morris Jr.
John Mossberg
Mountain Health CO-OP
Brad Mumau
Robert Nance*
Dr. Laura Nathan
Diana Navarre
Maysarih Ndobe
Michael Neal
Nickles Bakery
Pam Niese
Dr. Jesse Nodora
Northcross Group
Gary Offerdahl
Albert Orr III
P & K Farms
Stephanie Patrick
C.B. Pearson
Kassy Perry
Jordan Poyer
Gary Premier
Paula Ragan
Reach Beyond Solutions
Susan Regier*
Michael Reich
Kael Reicin
Hugo Ricci
Robert Boissoneault Oncology Institute
Tyler Rockers
Rockland Trust
Patsy Romero
Judy Rospenda
Bernice Sanders
Elizabeth Sanderson
Tara Scott
Michael Semenza
Cynthia Serna
SERVPRO of Mankato/Owatonna
Sevenson Environmental Services, Inc.
Beth Shissler
Peggy Silbert
Kim Smarsh
Neal Spencer
Spiegel’s South Shore
Scrap Metal
Amanda Stanton
Team Steadman
Erica Storm
Eugene Stuart
TJ Sullivan
Tennessee School of Beauty
Lu-Shawn Thompson
Glenn Tilton
Jacqueline Tilton
Jennifer True
Lee Turner
Twelve Pins Chicago, Inc.
Nevette Tyus-Middleton
University of Kansas
Cancer Center
Valley Credit Union
Heidi Varner
Rajeev Vasudeva
Veritas Advisors LLP
Walmart
Walmart Foundation
Gina Walsh
Teresa Warnock
West Virginia University
Ann Wheet
Wolfe County Farm Bureau Insurance
Dick Woodruff
Lisa Worthington
Z Global, Inc.
Paul Adam
Zeke Aguilera
Kathy Aherne
Applebee’s
Michelle Appleby
Patty Avery
Dr. Lisa Bailey
Caroline Baker
Mark Bamforth
Lance Barbour
Shelly Barsanti
Carol Becker
Cindy Bedford
David Benson
Amy Bianchino
Doug Bland
Sam Blankenship
Michele Bloch
Michael Bogen
Carrie Boston
Karin Boyte Thompsen
Virginia Brase
Andrea Britcher
Terrance Britt
Scott Brock
Patricia Brown
Bulas Antiques and Collectibles, LLC
Denise Burns
Grant Cale
Jackie Cale
Cathryn Callaway
Anthony Calvelage
Mark Cameli
Frank Cardinal III
Linda Carlson
Pearl Carter
Luke Cavener
Elisheva Chamblin
Sharon Chicano
Ben Choice
Jody Clark
Janet Clearwater
Tiffany Cloud
Margaret Coffey
Rick Cole
Karen Connor
Jennifer Coston
JoAnne Cousino
Roger Crawford
Cross Mahoney
Living Trust
Rossana Cuellar
Scott Cushing
Dacey Insurance
Agency, Inc.
Marie-Michele Darcy
Lori Davies
Dimple Davis
Xavier Decaire
Linda DeGarmo
Judy Delfabro
Sarah Domm
Richard Douglas
Lori Drew
Sharon Dymnioski
Karen Dziedzic
Denice Economou
Mavis Edme
Rachael Eerdmans
Don Enslow
Damian Eonta
Melissa Erickson
Glenn Eyrich
Falvello Law Firm
Amy Farner
Jeffrey Feldman
Stephen Fetzer
Suzanne Fink
First Baptist Church Fannin
Kathy Flaherty
Joann Flegel
Nathan Forrester
Maryjo Foseid
Elaine Franco
Marlene Fraser
Nancy Freeman
Friends of
John Shott 2018
Lori Garcia
Gastroenterology
Specialties, P.C.
Allen Gee
Sandra Geroux
Jeff Gillis
Miles Goda
Scott Goodlin
Bernard Goulding Jr.
Gould’s Supermarket, Inc.
Dr. Bobby Graham Jr.
Kay Graven
Kimberly Green
Kerry Grisolano
Jamie Gross
Gregg Haifley
Heather Hall
Marcus Hall
Meloni Hallock
Ken Hamm
Richard Harkess
Stacey Harmon-Roeber
Robert Harris
Julianne Hart
Jill Haupt
Todd Hauptli
Patricia Heaston
Ruth Heineman
Tad Heitmann
Deanna Henkle
Sean Hennen
Edith Hitchings
John Hoctor
Linda Holden
Gloria Holtz
Jacqueline Hoskins
Rosilyn Houston
Dr. Esther Jacobs
The John Lewis Family
Robert Johnson Jr.
Mary Jones
Patricia Jury
William Kelly
George Kendall
Sally Kennedy
Kelly Kenyon
Kent Kepler
Allen Kessler
Travis Ketterman
Rani Khetarpal
Patrick Killen
Riguey King
Sherwood Kingsley
Kristopher Kipp
Kerstin Kirchner
Mary Ann Klefisch
Patricia Knight
Eric Konigsberg
Karl Kruger
Heidi LaBree
Marc Lacasse
Anita Lambert
Crystal Landavazo
Teresa Lane
Dr. Walter Lawrence Jr.
Rose Marie Layman
Lyndia Lewis
Scott Lewis
David Light
Elizabeth Lippman
Joe Loughrey
Luce Research
Mark Lundy
Donna Lutke
J.P. Mann
Malcolm Manwell
Joe Marchetta
Andrea Marks
Carla Martin
Elizabeth Martin
Lori Martin
Amy Martinez
Auda Martinez
Percy Martinez
Ann Massey
Janet Mata
Charles Matthau
Mayo High School
Football Hall of Fame
Ashley McAuley
Kristen McEnroe
Colleen McGuire Schmitz
Stephen Medlin
Fred Meng
James Midtlien
Ellen Miller
Katharine Miller
Earl Minnis
Libby Mongue-Wymore
Colten Moore
Moose Ridge Associates
Blythe Moran
Arden Morris
Cheri Morrison
Jamey Mosley
Mother Stewarts
Brewing Co., LLC
Linda Muccitelli
Music in the Park Fund
Emily Myatt
Nancy Neel
Louise Neiterman
Debra Nevels
Charles Nichols
Bryan Noble
Northstar Grill
Gail Nyari-Lazzaro
Rebecca Oechsner
Kathleen Ottele
Ronald Ours III
Jeffrey Pace
Diana Page
Jean Paul
Dr. Susan Perlman
Lynne Peters
Terrell Philen Jr.
Johnny Phillips
Tyler Piekarski
Pamela Pilgrim
Kathryn Powell
Robert Prieto
Professionals Plus
Realty, Inc.
Matt Prokop
David Pugach
Grace Pugh
Usha Raju
Lois Ramer
Sara Ramos
Donna Rennick
Renee Rettig
Andrea Ridenour
Hubert Riley
Theodore Riley Jr.
L. Scott Ritterbush
River Terrace Rehab & Healthcare Center
RMGY, Inc.
Catherine Roberts
Donna Roberts
Michael Rodriquez
David Rogers
Jitesh Rohatgi
Denise Romand
Duane Ross
Jenell Ross
Helaine Rothman
Gregg Rothschild
Teresa Rutherford
Alison Sachs
Sanderjian Therapies
Dr. Carmen Sato-Bigbee
Dr. Charles Saxe III
Christine Schaub
Robert Schechner
Zachary Schlagel
Danielle Scholz
Peter Sedlak
Jon Sexton
Shady Lane, Inc.
Lorraine Shalvoy
Karyn Shatzman
Jacky Sher Raker
Sylvia Sherman
William Sherman II
Lindsi Shrock
Rose Shulgay
Marlene Sincaglia
Lana Skirboll
Robert Soles
Richard Soll
Southworth-Milton
Gwen Spencer
Matt Spiegel
Ann Stangl
Citseko Staples Miller
Eric Stern
Stoddard American Legion Post 315, Inc.
Noe Streetman
Jane Streets
Diana Sulewski
Ronald Sulewski
Angela Sylling
Joyce Thibodeaux
Leon Thomas
Thompson Cancer Survival Center
Allison Thomson
Jeanne Thornhill
William Tobin
Barbie Todd
Toma for City Council
King Boyz Towing
John Tramontin
Beth Trierweiler
Stephen Tyrrell
Carol Van Hal Browne
Theresa Vawter
Katherine Vogt
Gerald Wages
Wayne Wallingford Jr.
Pamela Warshavsky
Ursula Webster
Harry Werlin
Mary Weyant
Dr. Richard White Jr.
Tony Williams
Carolyn Williams-Goldman
Scott Williford
Sylvia Wolf
Gordon Wright
Julie Wrigley
John Yadlosky
Greg Yoshii
Claudia Young
Michelle Zornes
*Contributor to the campaign opposing Oklahoma State Question 814, in defense of the Tobacco Settlement Endowment Trust, cancer research and tobacco cessation programs
1 of 21
2 of 21
3 of 21
4 of 21
5 of 21
6 of 21
7 of 21
8 of 21
9 of 21
10 of 21
11 of 21
12 of 21
13 of 21
14 of 21
15 of 21
16 of 21
17 of 21
18 of 21
19 of 21
20 of 21
21 of 21